Masimo | Beneficio Bruto En Ventas

Precio De Mercado
175.35
Cambio Diario
0.13 0.07%
Mensual
27.37%
Anual
-7.11%
Q1 Expectativa
169.93




Beneficio Bruto En Ventas Cambio Fecha
Abbott USD 6.54B 625M 2025-12
Accuray USD 41.89M 7.42M 2024-12
Align Technology USD 683.59M 44.39M 2025-12
AngioDynamics USD 38.86M 1.05M 2025-02
Artivion USD 61.01M 2.32M 2024-09
AtriCure USD 105.34M 4M 2025-12
Avanos Medical USD 86M 0 2025-12
Baxter International USD 577M 373M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Boston Scientific USD 3.68B 136M 2025-12
Dexcom USD 792.7M 61.3M 2025-12
Edwards Lifesciences USD 1.23B 18.7M 2025-12
General Electric Aerospace USD 3.8B 118M 2025-12
Globus Medical USD 535.95M 49.28M 2025-12
Haemonetics USD 202.39M 7.64M 2025-12
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
Intuitive Surgical USD 1.9B 241.9M 2025-12
Masimo USD 230.6M 2.7M 2025-09
Medtronic USD 5.41B 27M 2025-12
Orthofix International USD 545.88M 410.83M 2024-12
Owens Minor USD 526.01M 53.75M 2025-03
ResMed USD 878.72M 57.9M 2025-12
Steris USD 655.5M 9.6M 2025-12
Stryker USD 4.49B 633M 2025-12
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Thermo Fisher Scientific USD 4.64B 419M 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12


Masimo Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2026.